IMNM

Immunome Inc.

Phase 3 AI-extracted

varegacestat

desmoid tumors

Resolved

218days ago

Phase 3 readout · Dec 1, 2025

What's at stake Phase 3 trial results for varegacestat in desmoid tumors are due Dec 1, 2025. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 15h ago

“positive topline results from the global pivotal Phase 3 RINGSIDE trial of varegacestat in patients with progressing desmoid tumors.”

Add to calendar Post on X Reddit

Provenance